Bladder cancer trials in China

In China 167 Also abroad 626

167 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Evaluate 9MW2821 Versus Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer
Where
Shanghai
Age
18 years to 75 years
People
432
Run by
Mabwell (Shanghai) Bioscience Co., Ltd.
See details and how to joinNCT06196736
Phase 1Taking people
Pilot Study on Rutin Combined With Tislelizumab and GC (Gemcitabine and Cisplatin) as Neoadjuvant Therapy for Platinum-refractory Muscle-invasive Bladder Cancer
Where
Chongqing
Age
18 years and over
People
10
Run by
First Affiliated Hospital of Chongqing Medical University
See details and how to joinNCT06916494
Phase 2Taking people
Probiotics in Advanced Urothelial Carcinoma
Where
Guangzhou, Wuhan
Age
18 years and over
People
222
Run by
Sun Yat-sen University
See details and how to joinNCT06904573
Phase 1Taking people
Irinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthracyclines Treatment
Where
Chongqing
Age
18 years and over
People
18
Run by
First Affiliated Hospital of Chongqing Medical University
See details and how to joinNCT06766266
Phase 2Taking people
9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma
Where
Changsha, Nanjing
Age
18 years to 80 years
People
60
Run by
Mabwell (Shanghai) Bioscience Co., Ltd.
See details and how to joinNCT06823427
No phaseTaking people
Immediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder Cancer
Where
Shanghai
Age
18 years and over
People
72
Run by
Changhai Hospital
See details and how to joinNCT06889623
No phaseTaking people
A Bladder-Sparing Treatment Strategies of Large-Volume Non-Muscle-Invasive Bladder Cancer
Where
Nanjing
Age
18 years to 80 years
People
60
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06735287
No phaseTaking people
The Efficacy of Gallium[68Ga]NOTA-DNA Multivalent SGC8 Injection for Bladder Tumour Imaging
Where
Shanghai
Age
18 years to 85 years
People
20
Run by
RenJi Hospital
See details and how to joinNCT06763354
Phase 3Not yet taking people in China
A Clinical Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma.
Where
Changsha, Guangzhou, Wuhan
Age
18 years and over
People
210
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06364904
Phase 3Taking people
Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients
Where
Wuhan, Xiangyang
Age
18 years to 75 years
People
180
Run by
Shaogang Wang
See details and how to joinNCT06696794
Phase 1/2Taking people
A Study of SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBC
Where
Beijing
Age
18 years and over
People
150
Run by
Shanghai Hengrui Pharmaceutical Co., Ltd.
See details and how to joinNCT05410730
No phaseTaking people
Ultrasound Contrast-Enhanced Accurate Diagnosis of Preoperative Staging of Bladder Cancer
Where
Guangzhou
Age
18 years to 75 years
People
480
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06775977
Phase 2Taking people
A Study of RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial Carcinoma
Where
Nanjing
Age
18 years and over
People
30
Run by
Jinling Hospital, China
See details and how to joinNCT05917158
Phase 1Taking people
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBC
Where
Beijing, Changsha, Chengdu, Guangzhou, Haerbin, Jinan, Qingdao, Shanghai, Taiyuan, Tianjin, Wenzhou, Wuhan, Zhengzhou
Age
18 years and over
People
152
Run by
Jiangsu Simcere Pharmaceutical Co., Ltd.
See details and how to joinNCT06186414
No phaseTaking people
Preoperative Detection of Muscle Invasion in Bladder Cancer with Contrast-enhanced Ultrasonography
Where
Guangzhou
Age
18 years to 75 years
People
1,000
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT05204108
Phase 1/2Taking people
Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer
Where
Beijing, Changsha, Shanghai, Shenyang, Tianjin, Xiamen
Age
18 years and over
People
48
Run by
Zhuhai Beihai Biotech Co., Ltd
See details and how to joinNCT06732531
Phase 1Taking people
A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of Intermediate and High-risk Non-muscle Invasive Bladder Cancer (NMIBC)
Where
Shanghai
Age
18 years and over
People
170
Run by
Shanghai Hengrui Pharmaceutical Co., Ltd.
See details and how to joinNCT06108492
Phase 2Taking people
PD1 Inhibitors Combined With Clostridium Butyricum for Urothelial Carcinoma
Where
Nanjing
Age
18 years and over
People
60
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06696742
Phase 2Taking people
A Phase 2 Clinical Study of ABSK061 and ABSK043
Where
Changsha, Changzhi, Chengdu, Guiyang, Hangzhou, Harbin, Jinan, Nanchang, Shanghai, Shenyang, Shijiazhuang, Tianjin, Wuhan, Xiamen, Xi'an, Xiangyang, Xuzhou, Zhengzhou
Age
18 years and over
People
202
Run by
Abbisko Therapeutics Co, Ltd
See details and how to joinNCT06632262
Phase 1/2Taking people
A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma
Where
Guangzhou
Age
18 years and over
People
90
Run by
Shanghai Hengrui Pharmaceutical Co., Ltd.
See details and how to joinNCT06639347
No phaseTaking people
Postoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUC
Where
Beijing
Age
18 years to 80 years
People
60
Run by
Peking University First Hospital
See details and how to joinNCT06598761
No phaseTaking people
A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology
Where
Binzhou, Dezhou, Jinan, Jining, Liaocheng, Linyi, Qingdao, Taian, Weifang, Yantai, Zaozhuang, Zibo
Age
18 years to 80 years
People
293
Run by
Qilu Hospital of Shandong University
See details and how to joinNCT06662071
No phaseTaking people
Radical Radiotherapy Versus Radical Surgery for UTUC
Where
Beijing
Age
18 years to 80 years
People
60
Run by
Peking University First Hospital
See details and how to joinNCT06652009
No phaseTaking people
Radiotherapy Combined with Systemic Therapy Versus Systemic Therapy for Oligometastatic UTUCs
Where
Beijing
Age
18 years to 80 years
People
102
Run by
Peking University First Hospital
See details and how to joinNCT06652022
Phase 2Not yet taking people in China
A Clinical Trial Evaluating the Efficacy and Safety of Disitamab Vedotin Plus Tislelizumab Combined with Re-TURBT in the Treatment of HER-2-high Expression(2+-3+) Non-muscle Invasive Bladder Cancer At High-risk and Very High-risk.
Where
Fuzhou
Age
18 years to 85 years
People
40
Run by
Fujian Medical University Union Hospital
See details and how to joinNCT06630871